Loading...

G Medical Innovations Holdings Ltd

GMVD•NASDAQ
Healthcare
Medical - Instruments & Supplies
$0.18
$0.003(1.38%)

G Medical Innovations Holdings Ltd (GMVD) Stock Overview

Explore G Medical Innovations Holdings Ltd’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.3/100

Key Financials

Market Cap1.8M
P/E Ratio0.00
EPS (TTM)$-18.76
ROE2.09%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.03

GMVD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of G Medical Innovations Holdings Ltd (GMVD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 1.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for GMVDStats details for GMVD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for GMVDAnalyst Recommendations details for GMVD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.

CEO

Yacov Geva

Employees

84

Headquarters

5 Oppenheimer Street, Rehovot

Founded

2021

Frequently Asked Questions

;